Randomized Control of Sympathetic Drive With Continuous Intravenous Esmolol in Patients With Acute ST-Segment Elevation Myocardial Infarction: The BEtA-Blocker Therapy in Acute Myocardial Infarction (BEAT-AMI) Trial

JACC: Cardiovascular Interventions

Volumn 9, Issue 3, 2016, Pages 231-240

  Er, Fikret ^a   Dahlem, Kristina M ^b   Nia, Amir M ^c   Erdmann, Erland ^b   Waltenberger, Johannes ^a   Hellmich, Martin ^d   Kuhr, Kathrin ^d   Le, Minh Tam ^b   Herrfurth, Tina ^b   Taghiyev, Zulfugar ^e   Biesenbach, Esther ^f   Yüksel, Dilek ^a   Eran Ergöknil, Aslihan ^a   Vanezi, Maria ^b   Caglayan, Evren ^b   Gassanov, Natig ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^d UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^e RUHR UNIVERSITY BOCHUM   (Germany)

^f UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

beta blocker; clinical trial; heart rate; STEMI; sympathetic nervous system

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATINE KINASE MB; ESMOLOL; PLACEBO; TROPONIN T; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76); PROPANOLAMINE DERIVATIVE;

ADULT; ARTICLE; ATRIOVENTRICULAR BLOCK; CARDIOGENIC SHOCK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATINE KINASE BLOOD LEVEL; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE INJURY; HEART RATE; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REPERFUSION; SINGLE BLIND PROCEDURE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; BLOOD; GERMANY; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; SHOCK, CARDIOGENIC; TACHYCARDIA, VENTRICULAR;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; BIOMARKERS; CREATINE KINASE; FEMALE; GERMANY; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; PROPANOLAMINES; PROSPECTIVE STUDIES; SHOCK, CARDIOGENIC; SINGLE-BLIND METHOD; TACHYCARDIA, VENTRICULAR; TROPONIN T;

EID: 84977622691     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2015.10.035     Document Type: Article

References (48)

1. 1 Noman, A., Balasubramaniam, K., Das, R., et al. Admission heart rate predicts mortality following primary percutaneous coronary intervention for ST-elevation myocardial infarction: an observational study. Cardiovasc Ther 31 (2013), 363–369.
2. 2 Parodi, G., Bellandi, B., Valenti, R., et al. Heart rate as an independent prognostic risk factor in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Atherosclerosis 211 (2010), 255–259.
3. 3 Graham, L.N., Smith, P.A., Huggett, R.J., Stoker, J.B., Mackintosh, A.F., Mary, D.A., Sympathetic drive in anterior and inferior uncomplicated acute myocardial infarction. Circulation 109 (2004), 2285–2289.
4. 123I]m-iodobenzylguanidine imaging in patients with ST-segment elevation myocardial infarction. Heart 97 (2011), 20–26.
5. 5 Ostrowski, S.R., Pedersen, S.H., Jensen, J.S., Mogelvang, R., Johansson, P.I., Acute myocardial infarction is associated with endothelial glycocalyx and cell damage and a parallel increase in circulating catecholamines. Crit Care, 17, 2013, R32.
6. 6 Mueller, H.S., Ayres, S.M., Propranolol decreases sympathetic nervous activity reflected by plasma catecholamines during evolution of myocardial infarction in man. J Clin Invest 65 (1980), 338–346.
7. 7 Vandongen, R., Davidson, L., Beilin, L.J., Barden, A.E., Effect of beta-adrenergic receptor blockade with propranolol on the response of plasma catecholamines and renin activity to upright tilting in normal subjects. Br J Clin Pharmacol 12 (1981), 369–374.
8. 8 O'Gara, P.T., Kushner, F.G., Ascheim, D.D., et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 61 (2013), e78–e140.
9. 9 Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology (ESC), Steg, P.G., James, S.K., Atar, D., et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 33 (2012), 2569–2619.
10. 10 Chen, Z.M., Pan, H.C., Chen, Y.P., et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 366 (2005), 1622–1632.
11. 11 Kaye, D.M., Smirk, B., Finch, S., Williams, C., Esler, M.D., Interaction between cardiac sympathetic drive and heart rate in heart failure: modulation by adrenergic receptor genotype. J Am Coll Cardiol 44 (2004), 2008–2015.
12. 12 Er, F., Erdmann, E., Nia, A.M., et al. Esmolol for tight heart rate control in patients with STEMI: design and rationale of the beta-blocker in acute myocardial infarction (BEAT-AMI) trial. Int J Cardiol 190 (2015), 351–352.
13. 13 Boden, H., Ahmed, T.A., Velders, M.A., et al. Peak and fixed-time high-sensitive troponin for prediction of infarct size, impaired left ventricular function, and adverse outcomes in patients with first ST-segment elevation myocardial infarction receiving percutaneous coronary intervention. Am J Cardiol 111 (2013), 1387–1393.
14. 14 Hall, T.S., Hallen, J., Krucoff, M.W., et al. Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Am Heart J 169 (2015), 257–265.e1.
15. 15 Hallen, J., Jensen, J.K., Fagerland, M.W., Jaffe, A.S., Atar, D., Cardiac troponin I for the prediction of functional recovery and left ventricular remodelling following primary percutaneous coronary intervention for ST-elevation myocardial infarction. Heart 96 (2010), 1892–1897.
16. 16 Steen, H., Giannitsis, E., Futterer, S., Merten, C., Juenger, C., Katus, H.A., Cardiac troponin T at 96 hours after acute myocardial infarction correlates with infarct size and cardiac function. J Am Coll Cardiol 48 (2006), 2192–2194.
17. 17 Alderman, E., Stadius, M., The angiographic definitions of the Bypass Angioplasty Revascularization Investigation. Coron Artery Dis, 1992, 1189–1207.
18. 18 Graham, M.M., Faris, P.D., Ghali, W.A., et al. Validation of three myocardial jeopardy scores in a population-based cardiac catheterization cohort. Am Heart J 142 (2001), 254–261.
19. 19 Steg, P., Lopez-de-Sa, E., Schiele, F., et al. Safety of intravenous ivabradine in acute ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention: a randomized, placebo-controlled, double-blind, pilot study. Eur Heart J Acute Cardiovasc Care 2 (2013), 270–279.
20. 20 Melsom, M., Andreassen, P., Melsom, H., Hansen, T., Grendahl, H., Hillestad, L.K., Diazepam in acute myocardial infarction. Clinical effects and effects on catecholamines, free fatty acids, and cortisol. Br Heart J 38 (1976), 804–810.
21. 21 Dixon, R.A., Edwards, I.R., Pilcher, J., Diazepam in immediate post-myocardial infarct period. A double blind trial. Br Heart J 43 (1980), 535–540.
22. 22 Brown, J.F., Valenzuela, T.D., Update: drug therapy for acute myocardial infarction. Compr Ther 17 (1991), 45–50.
23. 23 Hjalmarson, A., Elmfeldt, D., Herlitz, J., et al. Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial. Lancet 2 (1981), 823–827.
24. 24 Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group. Lancet 2 (1986), 57–66.
25. 25 Mehta, R.H., Montoye, C.K., Faul, J., et al. Enhancing quality of care for acute myocardial infarction: shifting the focus of improvement from key indicators to process of care and tool use: the American College of Cardiology Acute Myocardial Infarction Guidelines Applied in Practice Project in Michigan: Flint and Saginaw Expansion. J Am Coll Cardiol 43 (2004), 2166–2173.
26. 26 Chatterjee, S., Chaudhuri, D., Vedanthan, R., et al. Early intravenous beta-blockers in patients with acute coronary syndrome—a meta-analysis of randomized trials. Int J Cardiol 168 (2013), 915–921.
27. 27 Speidl, W.S., Toller, W.G., Kaun, C., et al. Catecholamines potentiate LPS-induced expression of MMP-1 and MMP-9 in human monocytes and in the human monocytic cell line U937: possible implications for peri-operative plaque instability. FASEB J 18 (2004), 603–605.
28. 28 Morelli, A., Ertmer, C., Westphal, M., et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA 310 (2013), 1683–1691.
29. 29 Ibanez, B., Macaya, C., Sanchez-Brunete, V., et al. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial. Circulation 128 (2013), 1495–1503.
30. 30 Pizarro, G., Fernandez-Friera, L., Fuster, V., et al. Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the METOCARD-CNIC trial (Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction). J Am Coll Cardiol 63 (2014), 2356–2362.
31. 31 Waltenberger, J., Gelissen, M., Bekkers, S.C., et al. Clinical pacing post-conditioning during revascularization after AMI. J Am Coll Cardiol Img 7 (2014), 620–626.
32. 32 Di Chiara, A., Dall'Armellina, E., Badano, L.P., Meduri, S., Pezzutto, N., Fioretti, P.M., Predictive value of cardiac troponin-I compared to creatine kinase-myocardial band for the assessment of infarct size as measured by cardiac magnetic resonance. J Cardiovasc Med 11 (2010), 587–592.
33. 33 Giannitsis, E., Steen, H., Kurz, K., et al. Cardiac magnetic resonance imaging study for quantification of infarct size comparing directly serial versus single time-point measurements of cardiac troponin T. J Am Coll Cardiol 51 (2008), 307–314.
34. 34 Hallen, J., Buser, P., Schwitter, J., et al. Relation of cardiac troponin I measurements at 24 and 48 hours to magnetic resonance-determined infarct size in patients with ST-elevation myocardial infarction. Am J Cardiol 104 (2009), 1472–1477.
35. 35 Vasile, V.C., Babuin, L., Giannitsis, E., Katus, H.A., Jaffe, A.S., Relationship of MRI-determined infarct size and cTnI measurements in patients with ST-elevation myocardial infarction. Clin Chem 54 (2008), 617–619.
36. 36 Schoenhagen, P., White, H.D., Magnetic resonance imaging and troponin elevation following percutaneous coronary intervention: new insights into myocyte necrosis and scar formation. J Am Coll Cardiol Intv 3 (2010), 959–962.
37. 37 Collinson, P.O., Biochemical estimation of infarct size. Heart 97 (2011), 169–170.
38. 38 Chin, C.T., Wang, T.Y., Li, S., et al. Comparison of the prognostic value of peak creatine kinase-MB and troponin levels among patients with acute myocardial infarction: a report from the Acute Coronary Treatment and Intervention Outcomes Network Registry-get with the guidelines. Clin Cardiol 35 (2012), 424–429.
39. 39 Chia, S., Senatore, F., Raffel, O.C., Lee, H., Wackers, F.J., Jang, I.K., Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. J Am Coll Cardiol Intv 1 (2008), 415–423.
40. 40 Hallen, J., Troponin for the estimation of infarct size: what have we learned?. Cardiology 121 (2012), 204–212.
41. 41 Licka, M., Zimmermann, R., Zehelein, J., Dengler, T.J., Katus, H.A., Kubler, W., Troponin T concentrations 72 hours after myocardial infarction as a serological estimate of infarct size. Heart 87 (2002), 520–524.
42. 42 Mayr, A., Mair, J., Klug, G., et al. Cardiac troponin T and creatine kinase predict mid-term infarct size and left ventricular function after acute myocardial infarction: a cardiac MR study. J Magn Reson Imaging 33 (2011), 847–854.
43. 43 Nienhuis, M.B., Ottervanger, J.P., de Boer, M.J., et al. Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction. Am Heart J 155 (2008), 673–679.
44. 44 Dohi, T., Maehara, A., Brener, S.J., et al. Utility of peak creatine kinase-MB measurements in predicting myocardial infarct size, left ventricular dysfunction, and outcome after first anterior wall acute myocardial infarction (from the INFUSE-AMI trial). Am J Cardiol 115 (2015), 563–570.
45. 45 Ezekowitz, J.A., Theroux, P., Welsh, R., Bata, I., Webb, J., Armstrong, P.W., Insights into the change in brain natriuretic peptide after ST-elevation myocardial infarction (STEMI): why should it be better than baseline?. Can J Physiol Pharmacol 85 (2007), 173–178.
46. 46 Kleczynski, P., Legutko, J., Rakowski, T., et al. Predictive utility of NT-pro BNP for infarct size and left ventricle function after acute myocardial infarction in long-term follow-up. Dis Markers 34 (2013), 199–204.
47. 47 Haeck, J.D., Verouden, N.J., Kuijt, W.J., et al. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol 105 (2010), 1065–1069.
48. 48 Verouden, N.J., Haeck, J.D., Kuijt, W.J., et al. Comparison of the usefulness of N-terminal pro-brain natriuretic peptide to other serum biomarkers as an early predictor of ST-segment recovery after primary percutaneous coronary intervention. Am J Cardiol 105 (2010), 1047–1052.